Epidemiology and outcome of the cardio-renal syndrome

Dinna N Cruz1, Mihai Gheorghiade, Alberto Palazzuoli

  • 1Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy.

Heart Failure Reviews
|January 4, 2011
PubMed

Insights

This review summarizes the epidemiology of cardio-renal syndrome (CRS) and its subtypes. Understanding these heart-kidney interactions is crucial for managing disease burden, morbidity, and mortality.

Area of Science:

  • Cardiology
  • Nephrology
  • Epidemiology

Background:

  • Cardiac and kidney diseases frequently coexist and pose significant clinical challenges.
  • The Acute Dialysis Quality Initiative (ADQI) Working Group developed a classification for cardio-renal syndrome (CRS) and its subtypes.
  • Existing guidelines acknowledge kidney dysfunction as a poor prognostic indicator in heart failure, yet patients with kidney issues are often excluded from trials.

Purpose of the Study:

  • To review the epidemiology of cardio-renal syndrome (CRS) and its distinct subtypes.
  • To highlight the importance of understanding the burden of disease, morbidity, mortality, and health resource utilization for each CRS subtype.
  • To identify knowledge gaps and inform the design of future clinical studies on cardio-renal interactions.

Main Methods:

  • This review synthesizes existing literature on the epidemiology of cardio-renal syndrome.
  • It focuses on data stratified by the proposed ADQI classification of CRS subtypes.
  • The review examines precipitating events, risk identification, natural history, and outcomes associated with CRS.

Main Results:

  • Cardio-renal syndrome (CRS) is a common condition with distinct subtypes, each having unique pathophysiologic mechanisms and clinical features.
  • Epidemiological data on CRS subtypes is essential for assessing disease burden, patient outcomes, and healthcare utilization.
  • There is a need for more research, particularly including patients with kidney dysfunction, in clinical trials for heart failure interventions.

Conclusions:

  • A comprehensive understanding of the epidemiology of cardio-renal syndrome (CRS) and its subtypes is critical for clinical practice and research.
  • Further investigation into the specific epidemiological characteristics of each CRS subtype is warranted.
  • Improved inclusion of patients with kidney dysfunction in clinical trials is necessary to advance the management of heart failure.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...